Physician profile
Thomas A Evans
NPI 1083643654
$1,363.44
in general payments reported to CMS, 2019-2025
16 companies · $88.81 in 2025
The $88.81 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $45.62 · 2021: $117 · 2022: $370 · 2023: $325 · 2024: $222 · 2025: $88.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $335.26 | 2022-2024 | Sprint Pns System |
| Mml US, INC. | $163.79 | 2022 | |
| Abbvie INC. | $155.94 | 2023-2025 | |
| Allergan, INC. | $138.34 | 2019-2022 | |
| Arthrex, INC. | $118.56 | 2019 | |
| Boston Scientific Corporation | $107.00 | 2021-2022 | |
| Stratus Medical, LLC | $80.12 | 2022-2023 | Nimbus |
| Zimmer Biomet Holdings, INC. | $57.83 | 2025 | Juggerknotless Soft Anchor, Rosa, Gel-One Cross-Linked Hyaluronate |
| Abbott Laboratories | $50.81 | 2021-2023 | Proclaim |
| Medtronic, INC. | $28.90 | 2021 | |
| Hydrocision, INC. | $28.71 | 2024 | Tenjet |
| Nevro Corp. | $24.61 | 2019 | |
| Vertos Medical, INC. | $24.28 | 2023 | Mild Device Kit |
| Medtronic USA, INC. | $19.02 | 2019 | |
| Bioventus LLC | $16.36 | 2023 | Durolane |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.